FGFR1 inhibitor-11 (compound 5g) effectively targets and binds to FGFR1, subsequently inhibiting the downstream signaling pathways ERK1/2 and IkappaBalpha/NF-kappaB, which results in the suppression of RANKL-induced osteoclastogenesis. This compound also exhibits oral bioactivity [1].
Molekulargewicht:
358.39
CAS Nummer:
[2157482-40-9]
Formel:
C23H18O4
Target-Kategorie:
FGFR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten